These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11990519)

  • 21. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late onset laryngeal stenosis following radiotherapy for head and neck carcinoma: a case series.
    Jayawardena J; O'Connor TE; White R; Chai F
    ANZ J Surg; 2012 Sep; 82(9):657-8. PubMed ID: 22943085
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of mucosal acute radiation injury during accelerated-hyperfractionted split course radiotherapy (CHA-CHA) in advanced head and neck neoplasms].
    Miszczyk L; Tarnawski R; Woźniak G; Maciejewski B
    Otolaryngol Pol; 2002; 56(5):543-9. PubMed ID: 12523161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.
    Willey CD; Murphy BA; Netterville JL; Burkey BB; Shyr Y; Shakhtour B; Kish B; Raben D; Chen C; Song JI; Kane MA; Cmelak AJ
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1323-31. PubMed ID: 17289289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is surgery necessary in stage III and stage IV cancer of the head and neck that responds to induction chemotherapy?
    Poulsen M; Aldren C; Tripcony L; Walker Q
    Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):467-71. PubMed ID: 8615961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer.
    Mortensen HR; Overgaard J; Specht L; Overgaard M; Johansen J; Evensen JF; Andersen LJ; Andersen E; Grau C
    Radiother Oncol; 2012 Apr; 103(1):69-75. PubMed ID: 22398313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity.
    Maciejewski B; Skladowski K; Pilecki B; Taylor JM; Withers RH; Miszczyk L; Zajusz A; Suwinski R
    Radiother Oncol; 1996 Aug; 40(2):137-45. PubMed ID: 8884967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
    Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
    Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.
    Fowler JF; Harari PM; Leborgne F; Leborgne JH
    Radiother Oncol; 2003 Nov; 69(2):161-8. PubMed ID: 14643953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck.
    Andrä C; Rauch J; Li M; Ganswindt U; Belka C; Saleh-Ebrahimi L; Ballhausen H; Nachbichler SB; Roeder F
    Radiat Oncol; 2015 Jul; 10():140. PubMed ID: 26156022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute toxicity of curative radiotherapy in elderly patients.
    Huguenin P; Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1996 Dec; 172(12):658-63. PubMed ID: 8972750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
    Lu H; Yao M; Tan H
    Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.
    Poulsen M; Denham J; Spry N; Lamb D; Peters L; Krawitz H; Penniment M; Williamson S; Tripcony L
    Australas Radiol; 1999 Nov; 43(4):487-94. PubMed ID: 10901965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Normal tissue tolerance to external beam radiation therapy: larynx and pharynx].
    Debelleix C; Pointreau Y; Lafond C; Denis F; Calais G; Bourhis JH
    Cancer Radiother; 2010 Jul; 14(4-5):301-6. PubMed ID: 20598610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity.
    Kaanders JH; van Daal WA; Hoogenraad WJ; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 1992; 24(3):497-503. PubMed ID: 1399736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer.
    Newman JP; Terris DJ; Pinto HA; Fee WE; Goode RL; Goffinet DR
    Ann Otol Rhinol Laryngol; 1997 Feb; 106(2):117-22. PubMed ID: 9041815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does preoperative irradiation increase the rate of surgical complications in carcinoma of the head and neck? A Radiation Therapy Oncology Group Report.
    Marcial VA; Gelber R; Kramer S; Snow JB; Davis LW; Vallecillo LA
    Cancer; 1982 Mar; 49(6):1297-301. PubMed ID: 7037159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.